Considering the therapeutic effects of XYAS and the bidirectional interaction between psoriasis and SDs (Nowowiejska et al., 2021), it is crucial to explore its specific pharmacological mechanism involving the regulation of the MLT-RORα axis, pro-inflammatory cytokines, and OS in psoriasis. This evidence concerns the gene RORA and psoriasis.